https://assets.capyfin.com/instruments/678fdc13234e27009c5d576c.png avatar
Option Care Health
🇺🇸 NASDAQ:OPCH
•
Dec 31, 2024

Option Care Health Q4 2024 Earnings Report

Option Care Health reported strong revenue and income growth in Q4 2024.

Key Takeaways

Option Care Health delivered solid financial results in Q4 2024 with net revenue growth of 19.7%, increased net income, and a higher adjusted EBITDA, demonstrating resilience in a dynamic market environment.

Net revenue increased by 19.7% to $1.35 billion.

Net income rose to $60.1 million, up from $57.2 million in Q4 2023.

Adjusted EBITDA grew by 8.9% to $121.6 million.

Adjusted diluted EPS increased by 15.8% to $0.44.

Total Revenue
$1.35B
Previous year: $1.12B
+19.8%
EPS
$0.44
Previous year: $0.32
+37.5%
Adjusted EBITDA
$122M
Cash Flow from Operations
$36.1M
Gross Profit
$268M
Previous year: $232M
+15.5%
Cash and Equivalents
$413M
Previous year: $344M
+20.0%
Free Cash Flow
$36.1M
Previous year: $31.1M
+16.1%
Total Assets
$3.42B
Previous year: $3.22B
+6.4%

Option Care Health Revenue

Option Care Health EPS

Option Care Health Revenue by Segment

Option Care Health Revenue by Geographic Location

Forward Guidance

Option Care Health expects revenue growth, strong adjusted EBITDA, and continued operational resilience in FY 2025.

Positive Outlook

  • Expected net revenue of $5.3 billion to $5.5 billion.
  • Adjusted EBITDA projected between $450 million and $470 million.
  • Adjusted diluted EPS anticipated between $1.59 and $1.69.
  • Cash flow from operations forecasted at $320 million or more.
  • Anticipated effective tax rate of 25%-27%.

Challenges Ahead

  • Ongoing inflationary pressures.
  • Potential interest expense increase.
  • Market uncertainties.
  • Impact of non-operating income.
  • Competitive pressures in the healthcare industry.

Revenue & Expenses

Visualization of income flow from segment revenue to net income